1254163-39-7

Basic information

• Product Name: N,N-dimethyl-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-terephthalamic acid methyl ester
• Synonyms: N,N-dimethyl-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-terephthalamic acid methyl ester
• CAS NO: 1254163-39-7
• Molecular Weight: 315.372
• Mol File: 1254163-39-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N,N-dimethyl-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-terephthalamic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N,N-dimethyl-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-terephthalamic acid methyl ester(1254163-39-7)
• EPA Substance Registry System: N,N-dimethyl-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-terephthalamic acid methyl ester(1254163-39-7)

Safety Data

• Hazardous Substances Data: 1254163-39-7(Hazardous Substances Data)

Upstream product

• 15801-69-1 4-bromo-1,3,5-trimethylpyrazole 
• 74-88-4 methyl iodide 

Relevant articles and documents

IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES

The invention provides compounds of the formula (I): and salts, tautomers, solvates and N-oxides thereof; wherein Q is CH or N; X is N, N+-O- or CR3; Y is N, N+-O- or CR3a; R1 and R2 are independently selected from hydrogen and various substituents as defined in the claims; or R1 and R2 together with the atoms to which they are attached, link to form an optionally substituted carbocyclic or heterocyclic aromatic or non-aromatic ring of 4 to 7 members; R3 is selected from hydrogen and various substituents; and R3a is selected from hydrogen and various substituents as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds. The compounds of formula (I) have activity as inhibitors of CDK kinases and are useful in the treatment of inter alia proliferative diseases such as cancers.